Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Open accessThe DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Abstract
Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to approximately 300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [403]
In the citing paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [126]
Citations
Cites
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 1×
“markers (Dib et al. 1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodSelf-citationHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Osteoclast formation and activation involve the receptor activator of NF-kB (RANK) pathway, a tumor-necrosis factor (TNF) family member (Hsu et al. 1999).”
BackgroundThe staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Both strands were analyzed using STADEN package 1.1 (Staden 1996).”
MethodInfluentialSobel, E. M., & Lange, K. L. (1996) · PubMed Central · Cited by 1,176
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 6×
“1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al. 1999).”
BackgroundInfluentialMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 1×
“Activating mutations of the TNFRSF11A gene encoding this receptor have been found to be responsible for FEO and rare cases of early-onset familial PDB (Hughes et al. 2000).”
BackgroundThe atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialThe interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluential
Research works printed but not linked: 1
- Glaser, 1999, Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism, Hum Mutat, 14, 23, 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-# · doi:10.1002/(sici)1098-1004(1999)14:1<23::aid-humu3>3.0.co;2-#
Cited by
Autophagy: process and function
Mizushima, N. (2007) · Genes & Development · doi:10.1101/gad.1599207 · Cited by 3,967
“2007) and is mutated in Paget disease patients (Laurin et al. 2002).”
BackgroundAutophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
Watts, G. D. J., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., & Kimonis, V. E. (2004) · Nature Genetics · doi:10.1038/ng1332 · Cited by 1,391
Translational biology of osteosarcoma
Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294
The molecular understanding of osteoclast differentiation
Asagiri, M., & Takayanagi, H. (2007) · Bone · doi:10.1016/j.bone.2006.09.023 · Cited by 1,363
RANKL–RANK signaling in osteoclastogenesis and bone disease
Wada, T., Nakashima, T., Hiroshi, N., & Penninger, J. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.007 · Cited by 1,212
p62 at the crossroads of autophagy, apoptosis, and cancer
Moscat, J., & Diaz-Meco, M. T. (2009) · Cell · doi:10.1016/j.cell.2009.05.023 · Cited by 1,073
Ubiquitin and ubiquitin-like proteins as multifunctional signals
Welchman, R. L., Gordon, C., & Mayer, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1700 · Cited by 828
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Protein Turnover Via Autophagy: Implications for Metabolism
Mizushima, N., & Klionsky, D. J. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093749 · Cited by 792
“The p62/SQSTM1 mutation is associated with Paget disease of the bone in human (57), and p62 knockout mice develop mature-onset obesity (96).”
BackgroundAutophagy as a promoter of longevity: insights from model organisms
Hansen, M., Rubinsztein, D. C., & Walker, D. W. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0033-y · Cited by 754
Jiang, P., & Mizushima, N. (2014) · Cell Research · doi:10.1038/cr.2013.161 · Cited by 775
Seibenhener, M. L., Babu, J. R., Geetha, T., Wong, H. C., Krishna, N. R., & Wooten, M. W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8055-8068.2004 · Cited by 710
“Recent studies have revealed that mutations in the UBA domain of p62 segregate with Paget’s disease, a disorder characterized by risk of fracture, neurological complications, and increased risk of osteosarcoma (21, 26, 36 ).”
Backgroundp62 links autophagy and Nrf2 signaling
Jiang, T., Harder, B., Rojo de la Vega, M., Wong, P. K., Chapman, E., & Zhang, D. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.014 · Cited by 639
“p62 is an autophagy adaptor protein, initially identified as a tyrosine kinase p56lck binding protein, that gained more attention when mutations in p62 were found to be associated with Paget's disease of bone [23–25].”
Autophagy genes in biology and disease
Yamamoto, H., Zhang, S., & Mizushima, N. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00562-w · Cited by 623
An overview of the regulation of bone remodelling at the cellular level
Kular, J., Tickner, J., Chim, S. M., & Xu, J. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.03.021 · Cited by 534
Physiological significance of selective degradation of p62 by autophagy
Komatsu, M., & Ichimura, Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.017 · Cited by 517
“Furthermore, p62/A170/ SQSTM1 (hereafter referred to as ‘p62’), which interacts with several signaling molecules [3] and whose mutations give rise to inherited Paget’s disease [4], is present in the ubiquitin-inclusions”
BackgroundValosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
Ju, J.-S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., & Weihl, C. C. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908115 · Cited by 494
“Consistent with VCP’s involvement in these processes, dominantly inherited mutations cause inclusion body myopathy (IBM), Paget’s disease of the bone (PDB), and frontotemporal dementia (FTD [IBMPFD]), which is a rare multisystem degenerative disorder with three variably penetrant phenotypic features (Watts et al., 200…”
InfluentialThe VCP/p97 system at a glance: connecting cellular function to disease pathogenesis
Meyer, H., & Weihl, C. C. (2014) · Journal of Cell Science · doi:10.1242/jcs.093831 · Cited by 430
“…frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and Paget’s disease of the bone (PDB), or ALS and PDB, further suggesting that a defect in this process is the underlying basis of VCP/p97-mediated disease pathogenesis (Laurin et al., 2002; Fecto et al., 2011; Rubino et al., 2012).”
BackgroundThe Osteoclast: Friend or Foe?
Novack, D. V., & Teitelbaum, S. L. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151431 · Cited by 381
“In approximately 30% of familial PD and a few sporadic cases, there is an activating mutation in p62 (146), an adaptor protein important for activating NFκB, p38, and MAPK.”
BackgroundDomain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease.
Hocking, L. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2735 · Cited by 350
“Irrespective of the underlying mechanisms, the data presented here show that sequestosome mutations are a common cause of PDB, and provide evidence in support of the hypothesis that PDB (19) and related syndromes such as FEO and expansile skeletal hyperphosphatasia (12,13) may occur as the result of mutational events…”
BackgroundInfluentialMoore, D. D., & Luu, H. H. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-319-07323-1_4 · Cited by 349
Roodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340
“reported a point mutation (P392L) in SQSTM1, which maps to chromosome 5q35, in two French Canadian Paget families and several unrelated patients (69).”
BackgroundAutophagy and neurodegeneration
Frake, R. A., Ricketts, T., Menzies, F. M., & Rubinsztein, D. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73944 · Cited by 332
“In addition to its genetic involvement in ALS, p62 is commonly found in aggregates in multiple neurodegenerative diseases, and mutations in SQSTM1 have been identified in Paget’s disease of the bone (52).”
BackgroundThe Role of the Selective Adaptor p62 and Ubiquitin-Like Proteins in Autophagy
Lippai, M., & Lőw, P. (2014) · BioMed Research International · doi:10.1155/2014/832704 · Cited by 322
Tanaka, S., Nakamura, K., Takahasi, N., & Suda, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00327.x · Cited by 320
Durán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00403-9 · Cited by 316
Self-citationSignal integration and diversification through the p62 scaffold protein
MOSCAT, J., DIAZMECO, M., & WOOTEN, M. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.12.002 · Cited by 315
Using Epidemiology and Genomics to Understand Osteosarcoma Etiology
Savage, S. A., & Mirabello, L. (2011) · Sarcoma · doi:10.1155/2011/548151 · Cited by 303
“Mutations in SQSTM1, a downstream scaffold protein in this pathway, are associated with familial Paget disease [92].”
BackgroundNuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 302
Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62
Rodriguez, A., Durán, A., Selloum, M., Champy, M.-F., Diez-Guerra, F. J., Flores, J. M., Serrano, M., Auwerx, J., Diaz-Meco, M. T., & Moscat, J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.011 · Cited by 290
“Interestingly, CELL METABOLISM 3, 211–222, MARCH 2006 ª2006 ELSEVIER INC. mutations in the p62 gene have been shown to cause the 5q35linked Paget’s disease of bone, a disorder characterized by aberrant osteoclastic activity (Laurin et al., 2002).”
BackgroundSQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Rubino, E., Rainero, I., Chiò, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e25df · Cited by 286
Albagha, O. M. E., Visconti, M. R., Alonso, N., Langston, A. L., Cundy, T., Dargie, R., Dunlop, M. G., Fraser, W. D., Hooper, M. J., Isaia, G., et al. (2010) · Nature Genetics · doi:10.1038/ng.562 · Cited by 283
p62/SQSTM1 – steering the cell through health and disease
Sánchez-Martín, P., & Komatsu, M. (2018) · Journal of Cell Science · doi:10.1242/jcs.222836 · Cited by 282
“Skeletal and muscular disorders Mutations in SQSTM1 are strongly associated with PDB (Laurin et al., 2002), a chronic and progressive skeletal disorder characterized by focal areas of increased and disorganized bone turnover (Numan et al., 2015).”
BackgroundInfluentialMolecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273
“SQSTM1 mediates signaling via IL-1/TNF pathway to NF-kB, and MAPK9, and is part of the RANK-signaling pathway (Laurin et al ., 2002).”
Pankiv, S., Lamark, T., Bruun, J.-A., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039925 · Cited by 266
Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration
Ramesh Babu, J., Lamar Seibenhener, M., Peng, J., Strom, A., Kemppainen, R., Cox, N., Zhu, H., Wooten, M. C., Diaz‐Meco, M. T., Moscat, J., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05340.x · Cited by 258
“Genetic studies have shown that mutations in p62 are linked to Paget disease (Laurin et al. 2002).”
BackgroundPathogenesis and management of Paget's disease of bone
Ralston, S. H., Langston, A. L., & Reid, I. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61035-1 · Cited by 260
Selective degradation of p62 by autophagy
Ichimura, Y., & Komatsu, M. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0220-1 · Cited by 245
“p62 is a ubiquitously expressed cellular protein that is conserved in metazoa but not in plants and fungi, and mutations have been identified in bone Paget disease [18].”
BackgroundThe overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia
Abramzon, Y. A., Fratta, P., Traynor, B. J., & Chia, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00042 · Cited by 244
“Mutations in Sequestosome-1 (SQSTM1) was initially discovered in patients with Paget’s disease of bone (Laurin et al., 2002) and linked to ALS and behavioral FTD in 2011 (Fecto et al., 2011).”
Backgroundp62: a versatile multitasker takes on cancer
Moscat, J., & Diaz-Meco, M. T. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.02.008 · Cited by 242
“This is consistent with a model whereby Ras-induced p62 overexpression kidnaps a physiological p62-TRAF6 interaction that is important in the activation of NF-κB in response to interleukin- 1 (IL-1) [28], nerve growth factor (NGF) [48], and RANK [11,49–52](Figure 4).”
Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology
Teyssou, E., Takeda, T., Lebon, V., Boillée, S., Doukouré, B., Bataillon, G., Sazdovitch, V., Cazeneuve, C., Meininger, V., LeGuern, E., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1090-0 · Cited by 241
“familial and 16 % of sporadic cases of PDB in the French Canadian population [27].”
BackgroundRoot, J., Merino, P., Nuckols, A., Johnson, M., & Kukar, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 238
When autophagy meets cancer through p62/SQSTM1.
Puissant, A., Fenouille, N., & Auberger, P. (2012) · Europe PMC (PubMed Central) · Cited by 236
Autophagic Regulation of p62 is Critical for Cancer Therapy
Islam, M. A., Sooro, M. A., & Zhang, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051405 · Cited by 233
Forman, M. S., Mackenzie, I. R., Cairns, N. J., Swanson, E., Boyer, P. J., Drachman, D. A., Jhaveri, B. S., Karlawish, J. H., Pestronk, A., Smith, T. W., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00005 · Cited by 228
NF-κB modulators in osteolytic bone diseases
Xu, J., Wu, H. F., Ang, E. S. M., Yip, K., Woloszyn, M., Zheng, M. H., & Tan, R. X. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.007 · Cited by 229
“Although the etiology of PDB is yet uncertain, there is a genetic predisposition for the disease, and recent genetic linkage studies have shown that chromosome 5-linked forms of PDB are caused by mutations in a gene on 5q35-QTER, which encodes the ubiquitin-binding protein, sequestasome1(SQSTM1)/p62 [57].”
BackgroundDiagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline
Ralston, S. H., Corral-Gudino, L., Cooper, C., Francis, R. M., Fraser, W. D., Gennari, L., Guañabens, N., Javaid, M. K., Layfield, R., O'Neill, T. W., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3657 · Cited by 225
“(8–10) The most important susceptibility gene for PDB is SQSTM1,(11,12) which encodes p62, a protein involved in the nuclear factor kappa B (NF-kB) signaling pathway.”
BackgroundOsteosarcoma in Paget's Disease of Bone
Hansen, M. F., Seton, M., & Merchant, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s211 · Cited by 212
Interaction between osteoblast and osteoclast: impact in bone disease.
Phan, T. C. A., Xu, J., & Zheng, M. (2004) · PubMed · doi:10.14670/hh-19.1325 · Cited by 206
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
“gressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
BackgroundCell Signaling and Function Organized by PB1 Domain Interactions
Moscat, J., Diaz-Meco, M. T., Albert, A., & Campuzano, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.002 · Cited by 197
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Zufiría, M., Gil-Bea, F. J., Fernández-Torrón, R., Poza, J. J., Muñoz-Blanco, J. L., Rojas-García, R., Riancho, J., & López de Munain, A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.004 · Cited by 194
“Among these, VCP and SQSTM1 are also related to early-onset Paget disease and inclusion body myopathy (Laurin et al., 2002; Haubenberger et al., 2005). ii.”
Paget's Disease of Bone: An Endocrine Society Clinical Practice Guideline
Singer, F. R., Bone, H. G., Hosking, D. J., Lyles, K. W., Murad, M. H., Reid, I. R., & Siris, E. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2910 · Cited by 194
“Mutations in the gene-producing sequestosome 1 increase susceptibility to the development of Paget’s disease (6), but there is incomplete penetrance of the disease in some family members who have been found to harbor gene mutations (7, 8).”
BackgroundLe Ber, I. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3849 · Cited by 187
SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence
Salazar, G., Cullen, A., Huang, J., Zhao, Y., Serino, A., Hilenski, L., Patrushev, N., Forouzandeh, F., & Hwang, H. S. (2020) · Autophagy · doi:10.1080/15548627.2019.1659612 · Cited by 184
“Also, Sqstm1 mutations are associated with Paget bone disease [59] and were also found in frontotemporal lobar degeneration and amyotrophic lateral sclerosis [60].”
BackgroundGenetic Disorders of the Skeleton: A Developmental Approach
Kornak, U., & Mundlos, S. (2003) · The American Journal of Human Genetics · doi:10.1086/377110 · Cited by 180
“Evaluation of the candidate gene SQSTM1 on chromosome 5q31 revealed several mutations in familial and sporadic cases of PDB (Hocking et al. 2002; Laurin et al. 2002).”
Backgroundp62 at the Interface of Autophagy, Oxidative Stress Signaling, and Cancer
Nezis, I. P., & Stenmark, H. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4394 · Cited by 176
Boning up on autophagy: The role of autophagy in skeletal biology
Shapiro, I. M., Layfield, R., Lotz, M., Settembre, C., & Whitehouse, C. (2014) · Autophagy · doi:10.4161/auto.26679 · Cited by 175
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone
the Genetic Determinants of Paget's Disease (GDPD) Consortium (2011) · Nature Genetics · doi:10.1038/ng.845 · Cited by 174
Sumimoto, H., Kamakura, S., & Ito, T. (2007) · Science's STKE · doi:10.1126/stke.4012007re6 · Cited by 172
Pathogenesis of Paget Disease of Bone
Ralston, S. H., & Layfield, R. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9599-0 · Cited by 169
Long, J., Gallagher, T. R. A., Cavey, J. R., Sheppard, P. W., Ralston, S. H., Layfield, R., & Searle, M. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704973200 · Cited by 178
Hocking, L. J., Lucas, G. J., Daroszewska, A., Cundy, T., Nicholson, G. C., Donath, J., Walsh, J. P., Finlayson, C., Cavey, J. R., Ciani, B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0403015 · Cited by 156
“While PDB is genetically heterogeneous,((5,7,8,16)) recent studies have shown that mutations affecting the UBA domain of SQSTM1 are an important cause of the disease.((10,11)) A recurrent proline-leucine mutation affecting codon 392 in the UBA domain of SQSTM1 (P392L) was first identified as a cause of PDB by Laurin e…”
BackgroundInfluentialSequestosome 1: Mutation Frequencies, Haplotypes, and Phenotypes in Familial Paget's Disease of Bone
Morissette, J., Laurin, N., & Brown, J. P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s207 · Cited by 164
“Of these loci, only the PDB3 locus has been confirmed by an independent sample,((19)) and the underlying gene had been identified as the sequestosome 1/p62 gene (SQSTM1/p62).((21)) Although the PDB2 locus may be linked to early-onset PDB,((22)) current data do not support this locus for the development of typical, adu…”
BackgroundMethodInfluentialSelf-citationMolecular mechanisms underlying osteoclast formation and activation
Troen, B. R. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00069-x · Cited by 181
p62/SQSTM1 at the interface of aging, autophagy, and disease
Bitto, A., Lerner, C. A., Nacarelli, T., Crowe, E. P., Torres, C. A., & Sell, C. (2014) · AGE · doi:10.1007/s11357-014-9626-3 · Cited by 167
“The human gene resides on chromosome 5g35 and encompasses a 16-kb segment of genomic DNA (Laurin et al. 2002). sqstm1 contains eight exons and is driven by a TATA-less promoter with three consensus sequences for SP1, three AP-1 sites, one NFκB site, and an antioxidant response element (ARE) (Vadlamudi and Shin 1998; J…”
Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62
DeJesus, R., Moretti, F., McAllister, G., Wang, Z., Bergman, P., Liu, S., Frias, E., Alford, J., Reece-Hoyes, J. S., Lindeman, A., et al. (2016) · eLife · doi:10.7554/elife.17290 · Cited by 145
“SQSTM1 is a multifunctional adaptor protein that is mutated and deregulated in several pathological conditions, including Paget disease, neurodegeneration, metabolic dysfunction or cancer (Laurin et al., 2002; Rodriguez et al., 2006; Rubino et al., 2012; Takamura et al., 2011).”
BackgroundCrockett, J. C., Mellis, D. J., Scott, D. I., & Helfrich, M. H. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1272-8 · Cited by 143
Epidemiology of Paget's Disease in Europe: The Prevalence Is Decreasing
Poór, G., Donáth, J., Fornet, B., & Cooper, C. C. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060704 · Cited by 153
Shi, J., Shaw, C. L., du Plessis, D., Richardson, A. M. T., Bailey, K. L., Julien, C. L., Stopford, C. L., Thompson, J. C., Varma, A. R., Craufurd, D., et al. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1079-4 · Cited by 154
“Intriguingly, mutations in P62 gene have been linked to Paget’s disease [13, 25], this latter condition also being present in that form of FTD known as IBMPFD [48, 54].”
BackgroundRole of p62/SQSTM1 in liver physiology and pathogenesis
Manley, S., Williams, J. A., & Ding, W.-X. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213489446 · Cited by 135
Cellular and Molecular Biology of Optineurin
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00005-7 · Cited by 122
“One such gene, the ubiquitin-associated domain of Sequestosome 1 (SQSTM1), was identified and its mutations were noted to affect about 10% of the patients with sporadic or familial PDB (Beyens et al., 2004; Falchetti et al., 2004; Hocking et al., 2002; Laurin et al., 2002).”
BackgroundInfluentialBreakthroughs in genetic studies of ankylosing spondylitis
Brown, M. A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem269 · Cited by 161
“These include CARD15/NOD2, the major susceptibility gene for Crohn’s disease [11]; sequestosome mutations causing Paget’s disease [ 12 ]; LRP5, a major gene for osteoporosis [13–15]; and a handful of others.”
BackgroundParkin-mediated ubiquitin signalling in aggresome formation and autophagy
Chin, L., Olzmann, J. A., & Li, L. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380144 · Cited by 143
“Mutations in the Ub-binding domain of p62, an adaptor that binds Lys63-linked polyubiquitin chains and promotes autophagic clearance of protein aggregates [28–30], cause Paget disease [38].”
BackgroundDaroszewska, A., van 't Hof, R. J., Rojas, J. A., Layfield, R., Landao-Basonga, E., Rose, L., Rose, K., & Ralston, S. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr172 · Cited by 131
“The fact that we observed an allele dose effect of the P394L mutation on disease severity and extent is consistent with previous reports that homozygotes or compound heterozygotes for SQSTM1 mutations generally have more severe and extensive disease than heterozygotes (22,32), although it should be noted that at least…”
BackgroundResultThe atypical PKCs in inflammation: NF‐κB and beyond
Díaz-Meco, M. T., & Moscat, J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01093.x · Cited by 146
“However, its ability to interact with TRAF6 is especially relevant from a pathophysiological point of view, due to the role of TRAF6 and NF-jB in bone remodeling through the control of osteoclastogenesis, and the fact that a series of well-defined mutations in p62 are associated with the Paget’s disease of bone (PDB),…”
BackgroundCiani, B., Layfield, R., Cavey, J. R., Sheppard, P. W., & Searle, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307416200 · Cited by 141
Kurihara, N., Hiruma, Y., Zhou, H., Subler, M. A., Dempster, D. W., Singer, F. R., Reddy, S. V., Gruber, H. E., Windle, J. J., & Roodman, G. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28267 · Cited by 127
“Both genetic and environmental factors have been proposed as contributing to the etiology of PD, and multiple families with an autosomal dominant mode of inheritance have been described (7, 8).”
BackgroundWang, L. L. (2005) · The Cancer Journal · doi:10.1097/00130404-200507000-00005 · Cited by 144
Management of Paget's disease of bone
Langston, A. L. (2004) · Rheumatology · doi:10.1093/rheumatology/keh243 · Cited by 124
“If such data were forthcoming they would have major implications for patients with familial PDB, since it is now possible to identify people within families who are genetically predisposed to developing the disease [48–50].”
BackgroundRea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T., & Xu, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1034 · Cited by 123
Update on the Epidemiology of Paget's Disease of Bone
Cooper, C. C., Harvey, N. C., Dennison, E. M., & van Staa, T. P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s201 · Cited by 123
“,((20)) in Quebec, have mapped a mutation in a gene on 5q35QTER, which encodes an ubiquitin-binding protein, sequestasome-1, as a candidate gene for Paget’s disease because of its association with the NF- B signaling pathway.”
BackgroundPKCζ at the crossroad of NF-κB and Jak1/Stat6 signaling pathways
Moscat, J., Rennert, P. D., & Díaz-Meco, M. T. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401823 · Cited by 137
“genetic disorder characterized by aberrant osteoclastogenic activity.(76) Although the p62-deficient mice are not osteopetrotic, they show a clear impairment in osteoclastogenesis in vivo when injected with the calciotropic hormone PTHrP.”
BackgroundMolecular control of the NEMO family of ubiquitin-binding proteins
Clark, K., Nanda, S. K., & Cohen, P. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3644 · Cited by 127
Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease
Kim, S., Eun, H. S., & Jo, E. (2019) · Cells · doi:10.3390/cells8010077 · Cited by 138
“Mutations of p62 are known to be associated with Paget’s disease of bone [150].”
BackgroundNakatsuka, K., Nishizawà, Y., & Ralston, S. H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.8.1381 · Cited by 124
“(9,10) More recently, domain-specific mutations in the sequestosome 1 gene (SQSTM1) have been found by two groups to be a common cause of late onset PDB.(11,12) The affected family members described here presented with a distinctive phenotype with clinical overlap of PDB, FEO, and ESH.”
BackgroundRare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
van der Zee, J., Langenhove, T. V., Kovács, G. G., Dillen, L., Deschamps, W., Engelborghs, S., Matěj, R., Vandenbulcke, M., Sieben, A., Dermaut, B., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1298-7 · Cited by 129
“A relationship between PDB and FTlD has been previously demonstrated by the identification of causal mutations in VCP in families segregating the rare syndrome of inclusion body myopathy with Paget disease of bone and frontotemporal lobar degeneration (IBMPFD) [38]. later studies demonstrated that VCP mutations expres…”
BackgroundInfluentialCytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate Nrf2-mediated stress response
Yang, Y., Willis, T. L., Button, R. W., Strang, C. J., Fu, Y., Wen, X., Grayson, P. R. C., Evans, T., Sipthorpe, R. J., Roberts, S. L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11671-2 · Cited by 120
Kurihara, N., Hiruma, Y., Yamana, K., Michou, L., Rousseau, C., Morissette, J., Galson, D. L., Teramachi, J., Zhou, H., Dempster, D. W., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.002 · Cited by 117
“At least 21 mutations in sequestosome 1/p62, a scaffold protein that plays a key role in RANKL signaling in OCL, are linked to PD, with p62 the most frequent mutation found (Laurin et al., 2002; Morissette et al., 2006; Ralston, 2002).”
BackgroundSelf-citationLoss of Ubiquitin-Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations
Cavey, J. R., Ralston, S. H., Hocking, L. J., Sheppard, P. W., Ciani, B., Searle, M. S., & Layfield, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041205 · Cited by 132
“(3,4) Positional cloning studies have shown that mutations in the SQSTM1 (also known as p62) gene are an important cause of familial and sporadic PDB.(5,6) Moreover, all 11 PDB-causing mutations of SQSTM1 described so far affect the ubiquitin-associated (UBA) domain of the p62 protein,(7–10) an ubiquitin-binding eleme…”
BackgroundProtein folding alterations in amyotrophic lateral sclerosis
Parakh, S., & Atkin, J. D. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.010 · Cited by 122
p62/ SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
Taniguchi, K., Yamachika, S., He, F., & Karin, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12301 · Cited by 129
“(20-50%) and sporadic (5-15%) Paget's disease of bone (PDB) [25-28].”
BackgroundOdagiri, S., Tanji, K., Mori, F., Kakita, A., Takahashi, H., & Wakabayashi, K. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0975-7 · Cited by 121
“Indeed, recent studies have shown that genetic truncation of murine nbr1 leads to an age-dependent increase in bone mass and bone mineral density through increased osteoblast differentiation and activity [43], whereas p62 has been identified as the causative gene for Paget’s disease of bone, which is characterized by…”
BackgroundThree novel mutations in SQSTM1 identified in familial Paget’s disease of bone.
Johnson-Pais, T. L., Wisdom, J. H., Weldon, K. S., Cody, J. D., Hansen, M. F., Singer, F. R., & Leach, R. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1748 · Cited by 110
“The primers used to amplify the eight SQSTM1 exons have been previously described (exons 1–8).((11)) The PCR products from all eight exons were purified by centrifugation through an ultrafree-MC filtration device (Millipore, Bedford, MA, USA) and sequenced on an ABI 3100 genetic analyzer (Applied Biosystems, Foster Ci…”
BackgroundMethodInfluentialIdentification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma
Takeuchi, K., Soda, M., Togashi, Y., Ota, Y., Sekiguchi, Y., Hatano, S., Asaka, R., Noguchi, M., & Mano, H. (2010) · Haematologica · doi:10.3324/haematol.2010.033514 · Cited by 110
“Mutations within SQSTM1 are identified in patients with Paget’s disease of bone.(22) SQSTM1 is located very near NPM, which is on 5q35.”
BackgroundA functional role for the p62–ERK1 axis in the control of energy homeostasis and adipogenesis
Lee, S. J., Pfluger, P. T., Kim, J. Y., Nogueiras, R., Duran, A., Pagès, G., Pouysségur, J., Tschöp, M. H., Diaz‐Meco, M. T., & Moscat, J. (2010) · EMBO reports · doi:10.1038/embor.2010.7 · Cited by 108
“The signalling adapter p62, also known as sequestosome 1, has been implicated in crucial cellular processes owing to its ability to interact with important signalling intermediaries in biochemical assays (Moscat et al, 2006; Moscat & Diaz-Meco, 2009).”
BackgroundPathobiology of Paget's Disease of Bone
Galson, D. L., & Roodman, G. D. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.2.85 · Cited by 119
“The most commonly found mutation C1215T causes an amino acid substitution of proline (P) to leucine (L) at codon 392 (p62) and is found in 10% of sporadic and 30% of familial Paget’s patients.[11-13] Several studies have indicated that Paget’s disease kindreds with p62 mutations show incomplete penetrance (15-20% of c…”
Background
Metadata
- Authors
- Laurin, N., Brown, J. P., Morissette, J., & Raymond, V.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Raymond, Vincent
- ORCID
- Brown, Jacques P.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 70
- Issue
- 6
- Pages
- 1582-1588
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379146
- OpenAlex
- W2011308707
- Cited by
- 563
- References
- 47
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 23 · 2022: 14 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 14 · 2016: 34 · 2015: 28 · 2014: 35 · 2013: 30 · 2012: 31
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4066 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds pour la Formation de Chercheurs et l'Aide à la Recherche
- Canadian Institutes of Health Research (MOP-3804)
- Fonds de Recherche du Québec - Santé
- Canada Foundation for Innovation (548)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Keywords
- Paget's disease of bone, p62, recurrent mutations, ubiquitin-associated domain, haplotype mapping, French-Canadian families, NF-κB signaling, genetic susceptibility, bone turnover
- MeSH terms
- Sequestosome-1 Protein, Base Sequence, Canada, Carrier Proteins, France, Genetic Testing, Haplotypes, Heterozygote, Homozygote, Humans, Molecular Sequence Data, Mutation, Osteitis Deformans, Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.